Pfizer on Monday officially walked away from its offer to purchase AstraZeneca for $120 billion, putting an end to a monthlong pursuit that would have tied up the trans-Atlantic pharmaceutical giants.
from WSJ.com: US Business http://ift.tt/1msxMZy
via IFTTT
from WSJ.com: US Business http://ift.tt/1msxMZy
via IFTTT
No comments:
Post a Comment